Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours

NCT02343718 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

NETWORK

Sponsor class

Conditions

Recurrent Lymphoma
Refractory Lymphoma
Solid Tumours
Central Nervous System

Interventions

DRUG: Vinblastine
DRUG: Temsirolimus

Sponsor

Canadian Cancer Trials Group

Collaborators

[object Object]